| Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 1 Infection (NCT04539483) | Heidelberg ImmunoTherapeutics GmbH | 2020-10-08 |
| A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis (NCT03521479) | Squarex, LLC | 2018-03-12 |
| Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1) (NCT03661541) | Squarex, LLC | 2017-03-02 |
| Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis (NCT02965781) | Squarex, LLC | 2016-12-01 |
| Trial on Efficacy and Safety of Pritelivir Ointment for Treatment of Labial Herpes (NCT02871492) | AiCuris Anti-infective Cures AG | 2016-11-29 |
| Study of a New Topical Natural Health Product for the Treatment of Herpes Labialis (NCT02582086) | Laboratoire Boreaderme Inc. | 2016-01-01 |
| Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores (NCT02483182) | Shulov Innovate for Science Ltd. 2012 | 2015-09-01 |
| Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis (NCT02265913) | Padagis LLC | 2014-10-06 |
| A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labialis (NCT02207881) | Yung Shin Pharm. Ind. Co., Ltd. | 2014-07-01 |
| Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis (NCT01971385) | Massachusetts General Hospital | 2013-10-01 |
| NB-001 Treatment of Recurrent Herpes Labialis (NCT01695187) | NanoBio Corporation | 2012-10-01 |
| An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode (NCT01653509) | GlaxoSmithKline | 2012-07-01 |
| Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old (NCT01574612) | Meda Pharmaceuticals | 2012-03-01 |
| Non-inferiority Comparison of Efficacy and Safety of Penciclovir 10mg/g to Acyclovir 50mg/g in the Treatment of Recurrent Herpes Labialis (NCT01257074) | EMS | 2012-02-01 |
| Study of a Cold Sore Patch for the Treatment of Herpes Labialis (NCT01484067) | Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc. | 2011-11-01 |
| Viral Infections in Healthy and Immunocompromised Hosts (NCT01306084) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-15 |
| Immune Evidence to the Consumption of Lactobacillus GG and FOS Consumption in Patients With Herpes Labialis (NCT03310294) | Sprim Advanced Life Sciences | 2010-09-14 |
| Botulinum Toxin A for Herpes Labialis (NCT01225341) | DeNova Research | 2010-08-01 |
| A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis (NCT00913692) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-06-01 |
| Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis (NCT00878072) | Novartis Pharmaceuticals | 2009-03-25 |
| Immune Response to the Consumption of Lactobacillus GG and FOS in Patients With Recurrent Herpes Labialis (NCT03307772) | Sprim Advanced Life Sciences | 2008-12-15 |
| Bioequivalence Study of Aciclovir 5% Cream in Japanese Healthy Volunteers (NCT00711776) | GlaxoSmithKline | 2008-04-10 |
| Phase 3 Clinical Study for the Treatment of Cold Sore (NCT00769314) | Valerio Therapeutics | 2007-05-01 |
| Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis (NCT00453401) | NanoBio Corporation | 2007-02-01 |
| Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis in Immunocompromised Patients (NCT00735761) | Medivir | 2006-12-01 |
| Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents (NCT00375570) | Medivir | 2006-10-01 |
| Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis (NCT00361881) | Medivir | 2006-07-01 |
| VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2 (NCT00306293) | GlaxoSmithKline | 2006-02-20 |
| Iontophoretic Application of Acyclovir Cream to Treat Recurrent Herpes Labialis (NCT00230867) | Transport Pharmaceuticals | 2005-04-01 |
| Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis (NCT00297011) | University of Utah | 2004-09-01 |
| Efficacy of Acyclovir in Combination With a Glucocorticosteroid on UV-Induced Herpes Labialis (NCT00736437) | Medivir | 1999-08-01 |